# 510(k) Summary - Calibrator for Automated Systems (C.f.a.s.) and C.f.a.s. CK-MB

# Introduction

Roche Diagnostics Corporation hereby submits this $5 1 0 ( \mathsf { k } )$ to provide notification of modifications to our Calibrator for automated systems (C.f.a.s.) and C.f.a.s. CK-MB.

1. C.f.a.s. was originally cleared for use in K990460, then modified in K033501 and K062319. 2. C.f.a.s. CK-MB was originally cleared for use in K003158.

Modifications to these devices include changing common source materials for three analytes

Human recombinant Gamma-glutamyltransferase (yGT) will replace porcine kidney yGT in C.f.a.s.   
Human recombinant Aspartate aminotransferase (AST) will replace porcine heart AST in C.f.a.s.   
Human recombinant Creatine Kinase Isoenzyme MB (CKMB) will replace porcine brain Creatine Kinase Isoenzyme BB (CK-BB) in C.f.a.s. CK-MB.

Submitter name, address, contact

Roche Diagnostics 9115 Hague Rd. PO Box 50416 Indianapolis, IN 46250 Phone: (317) 521-3380 Fax: (317) 521-2324

Contact Person: Susan Hollandbeck

Date prepared: June 16, 2010

# 510(k) Summary - Calibrator for Automated Systems (C.f.a.s.) and C.f.a.s. CK-MB, Continued

# Device names

Proprietary names:

1. Roche Diagnostics Calibrator for automated systems   
2. Roche Diagnostics Calibrator for automated systems CK-MB

# Common names:

1. C.f.a.s.   
2 C.f.a.s. CK-MB

Classification names:

1. Calibrator, Multi-analyte mixture   
2 Calibrator, Secondary

# Product Codes:

1. JIX   
2JIT

Device description

1. C.f.a.s. is for use in the calibration for automated Roche methods on Roche chemistry analyzers as specified in the enclosed value sheet. It is a lyophilized calibrator based on human serum.

2. C.f.a.s. CK-MB is for use in the calibration of Roche methods for the quantitative determination of the MB Isoenzyme of Creatine kinase on automated clinical chemistry analyzers. It is a lyophilized calibrator based on bovine serum albumin.

# Intended use

1. Calibrator for automated systems (C.f.a.s.) is for use in the calibration for automated Roche methods on Roche chemistry analyzers as specified in the value sheets.

2. C.f.a.s. (Calibrator for automated systems) CK-MB is for use in the calibration of Roche methods for the quantitative determination of CK-MB on Roche clinical chemistry analyzers as specified in the value sheets.

# Predicate devices

We claim substantial equivalence to the following currently marketed devices.

1. . Calibrator for automated systems cleared in K062319.   
2. Calibrator for automated systems CK-MB cleared in K003158.

Continued on next page

# 510(k) Summary - Calibrator for Automated Systems (C.f.a.s.) and C.f.a.s. CK-MB, Continued

# Substantial equivalence

Tables 1 and 2 compare the features of the modified devices with their predicate devices. The first is a comparison of C.f.a.s.; the second is a comparison for C.f.a.s. CK-MB.

Table 1: Comparison of C.f.a.s.   

<table><tr><td rowspan=1 colspan=1>Feature</td><td rowspan=1 colspan=1>C.f.a.s(Modified Device)</td><td rowspan=1 colspan=1>C.f.a.s. K062319(Predicate Device)</td></tr><tr><td rowspan=1 colspan=1>Intended Use</td><td rowspan=1 colspan=1>Calibrator for automated systems(C.f.a.s.) is for use in the calibration ofquantitative Roche methods on Rocheclinical chemistry analyzers asspecified in the value sheets.</td><td rowspan=1 colspan=1>Calibrator for automated systems(C.f.a.s) is for use in the calibration ofquantitative Roche methods on Rocheclinical chemistry analyzers asspecified in the lot specific valueshect.</td></tr><tr><td rowspan=1 colspan=1>Format</td><td rowspan=1 colspan=1>Lyophilized</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=3 colspan=1>Stability</td><td rowspan=1 colspan=1>Lyophilized calibrator 2 to 8 C until expiration dateReconstituted calibrator. 15 to 25 C for 8 hours. 2 to 8 C for 2 days. -15 to -25 C for 4 weeks (whenfrozen once)Total Bilirubin in reconstitutedcalibrator when stored protected from</td><td rowspan=3 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>light. 15 to 25 °C for 6 hours2 10 8 C for I day-15 to -25 °C for 2 weeks (whenfrozen once)Direct Bilirubin in reconstitutedcalibrator when stored protected from</td></tr><tr><td rowspan=1 colspan=1>light• 15 to 25 &#x27;C for 3 hours. 2 to 8 C for 8 hours-15 to -25 C for 2 weeks (whenfrozen once)</td></tr><tr><td rowspan=1 colspan=1>Levels</td><td rowspan=1 colspan=1>Single level</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>ReagentComposition</td><td rowspan=1 colspan=1>Lyophilized human serum withchemical additives and material ofbiological origin</td><td rowspan=1 colspan=1>Same</td></tr></table>

# 510(k) Summary - Calibrator for Automated Systems (C.f.a.s.) and C.f.a.s. CK-MB, Continued

Substantial equivalence (continued) Table 1, continued...   

<table><tr><td rowspan=1 colspan=1>Feature</td><td rowspan=1 colspan=1>C.f.a.s(Modified Device)</td><td rowspan=1 colspan=1>C.f.a.s. K062319(Predicate Device)</td></tr><tr><td rowspan=3 colspan=1>Traceability</td><td rowspan=1 colspan=1>Traceability for each constituent isdescribed in the reagent systeminstructions for use.Additional Refercnce Materials1SRM 909b and SRM 956for Calcium2SRM 929 and SRM 956for Magnesium3.SRM 914 and SRM 967for Creatinine Jaffe4SRM 909b (IDMS) and SRM 967for Creatinine Plus5SRM 909b (IDMS) and SRM 1951for Triglycerides GBReference Material Name Changes</td><td rowspan=3 colspan=1>SameReference Materials1.SRM 909bfor Calcium2. SRM 929for Magnesium3. SRM 914for Creatinine JaffeSRM 909b (IDMS)for Creatinine PlusSRM 909b (IDMS)for Triglycerides GBReference Material NamesT. CRM 470 for Albumin PlusPrimary Reference Materialfor SalicylateReference Method Publications1IFCC (1985), Manual for ALT2. IFCC (1985), Manual for AST3.IFCC (1991), Manual for CK4. IFCC (1994), Manual for LD</td></tr><tr><td rowspan=1 colspan=1>1.ERM DA470k for Albunin PlusPrimary Reference Material - USPfor SalicylateReference Method Publication Update</td></tr><tr><td rowspan=1 colspan=1>1. IFCC (2002), Manual for ALT2IFCC (2002), Manual for AST3. IFCC (2002), Manual for CK4. IFCC (2002), Manual for LD</td></tr><tr><td rowspan=1 colspan=1>ValueAssignment</td><td rowspan=1 colspan=1>Values to new lots are assigned byrunning them as samples aftercalibrating the system with apreviously assigned C.f.a.s. lot.Values are verified by using referencematerial, Master lot C.f.a.s., andpreviously assigned lots of C.f.a.s.</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>SourceMaterial</td><td rowspan=1 colspan=1>. Human recombinant yGT Human recombinant AST</td><td rowspan=1 colspan=1>Porcine kidney yGTPorcine heart AST</td></tr></table>

# 510(k) Summary - Calibrator for Automated Systems (C.f.a.s.) and C.f.a.s. CK-MB, Continued

Table 2: Comparison of C.f.a.s. CK-MB   

<table><tr><td rowspan=1 colspan=1>Feature</td><td rowspan=1 colspan=1>C.f.a.s. CK-MB(Modified Device)</td><td rowspan=1 colspan=1>C.f.a.s. CK-MB K003158(Predicate Device)</td></tr><tr><td rowspan=1 colspan=1>Intended Use</td><td rowspan=1 colspan=1>C.f.a.s. (Calibrator for automatedsystems) CK-MB is for usc in thecalibration of Roche methods for thequantitative determination of CK-MBon Roche clinical chemistry analyzersas specified in the value sheets.</td><td rowspan=1 colspan=1>C.f.a.s. (Calibrator for automatedsystems) CK-MB is for use in thecalibration of Roche methods for thequantitative determination of CK-MBon automated clinical chemistryanalyzers.</td></tr><tr><td rowspan=1 colspan=1>Format</td><td rowspan=1 colspan=1>Lyophilized</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Stability</td><td rowspan=1 colspan=1>Lyophilized calibrator. 2 to 8 &quot;C until expiration dateReconstituted calibrator. 15 to 25 C for 24 hours. 2 to 8 °C for 2 days. - 15 to -25 *C for 4 weeks (whenfrozen once)</td><td rowspan=1 colspan=1>Lyophilized calibrator, sameReconstituted calibrator 15 to 25 C for 24 hours. 2 to 8 C for 2 days. -20 °C for 1 month (when frozenonce</td></tr><tr><td rowspan=1 colspan=1>Levels</td><td rowspan=1 colspan=1>Single level</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>ReagentComposition</td><td rowspan=1 colspan=1>Lyophilized calibrator based onbovine scrum albumin with chemicaladditives and material of biologicalorigin.</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Traceability</td><td rowspan=1 colspan=1>Traceability for each constituent isdescribed in the reagent systeminstructions for use.</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>ValueAssignment</td><td rowspan=1 colspan=1>Values to new lots are assigned byrunning them as sanples aftercalibrating the systen with apreviously assigned C.f.a.s. CK-MBlot. Values are verified by usingreference material, Master lot C.f.a.sCK-MB, and previously assigned lotsof C.f.a.s. CK-MB.</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Sourcematerial</td><td rowspan=1 colspan=1> Human recombinant CK-MBHunan CK-MM</td><td rowspan=1 colspan=1>Porcine brain CK-BBHuman CK-MM</td></tr></table>

# 510(k) Summary - Calibrator for Automated Systems (C.f.a.s.) and C.f.a.s. CK-MB, Continued

# Constituents

Tables 3 and 4 catalog the constituent analytes and their biological source for both the modified and predicate devices. Table 3 summarizes C.f.a.s., a multi-analyte calibrator. For the modified C.f.a.s., the source material changes for two analytes, AST and $\gamma \mathrm { G T }$ .

Table 3: Constituents of C.f.a.s.   

<table><tr><td rowspan=1 colspan=2>C.f.a.s(Modified Device)</td><td rowspan=1 colspan=2>C.f.a.s. K062319(Predicate Device)</td></tr><tr><td rowspan=1 colspan=1>Analyte</td><td rowspan=1 colspan=1>Source</td><td rowspan=1 colspan=1>Analyte</td><td rowspan=1 colspan=1>Source</td></tr><tr><td rowspan=1 colspan=1>ALT/ALAT</td><td rowspan=1 colspan=1>Porcine heart</td><td rowspan=1 colspan=1>ALT/ALAT</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>AST/ASAT</td><td rowspan=1 colspan=1>Human, recombinant</td><td rowspan=1 colspan=1>AST/ASAT</td><td rowspan=1 colspan=1>Porcineheart</td></tr><tr><td rowspan=1 colspan=1>Albumin</td><td rowspan=1 colspan=1>Bovine plasma</td><td rowspan=1 colspan=1>Albunin</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Alkalinephosphatase</td><td rowspan=1 colspan=1>Human placenta (recombinant)</td><td rowspan=1 colspan=1>Alkalinephosphatase</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Amylase, total</td><td rowspan=1 colspan=1>Porcine pancreas</td><td rowspan=1 colspan=1>Amylase, total</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Amylase, pancreatic</td><td rowspan=1 colspan=1>Porcine pancreas</td><td rowspan=1 colspan=1>Amylase, pancreatic</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Bilirubin, direct</td><td rowspan=1 colspan=1>Endogenous and/or chemical additive</td><td rowspan=1 colspan=1>Bilirubin, direct</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Bilirubin, total</td><td rowspan=1 colspan=1>Endogenous and/or chemical additive</td><td rowspan=1 colspan=1>Bilirubin, total</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Calcium</td><td rowspan=1 colspan=1>Endogenous and/or chemical additive</td><td rowspan=1 colspan=1>Calcium</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Cholesterol</td><td rowspan=1 colspan=1>Bovine plasma</td><td rowspan=1 colspan=1>Cholesterol</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Cholinesterase</td><td rowspan=1 colspan=1>Human serum</td><td rowspan=1 colspan=1>Cholinesterase</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Creatine kinase</td><td rowspan=1 colspan=1>Rabbit muscle</td><td rowspan=1 colspan=1>Creatine kinase</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Creatinine</td><td rowspan=1 colspan=1>Endogenous and/or chemical additive</td><td rowspan=1 colspan=1>Creatinine</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>yGT</td><td rowspan=1 colspan=1>Human, recombinant</td><td rowspan=1 colspan=1>γGT</td><td rowspan=1 colspan=1>Porcinekidney</td></tr><tr><td rowspan=1 colspan=1>Glucose</td><td rowspan=1 colspan=1>Endogenous and/or chemical additive</td><td rowspan=1 colspan=1>Glucose</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Iron</td><td rowspan=1 colspan=1>Endogenous and/or chemical additive</td><td rowspan=1 colspan=1>Iron</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>•    Lactate</td><td rowspan=1 colspan=1>Endogenous and/or chemical additive</td><td rowspan=1 colspan=1>Lactate</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>LD (LDH)</td><td rowspan=1 colspan=1>Porcine heart</td><td rowspan=1 colspan=1>LD (LDH)</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Lipase</td><td rowspan=1 colspan=1>Human pancreas (recombinant)</td><td rowspan=1 colspan=1>Lipase</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Lithium</td><td rowspan=1 colspan=1>Chemical additive</td><td rowspan=1 colspan=2>N/A&#x27;</td></tr><tr><td rowspan=1 colspan=1>Magnesium</td><td rowspan=1 colspan=1>Endogenous and/or chemical additive</td><td rowspan=1 colspan=1>Magnesium</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Phosphorus</td><td rowspan=1 colspan=1>Endogenous and/or chemical additive</td><td rowspan=1 colspan=1>Phosphorus</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Salicylate</td><td rowspan=1 colspan=1>Chemical additive</td><td rowspan=1 colspan=1>Salicylate</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Total Protein</td><td rowspan=1 colspan=1>Endogenous and/or chemical additive</td><td rowspan=1 colspan=1>Total Protein</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Triglycerides</td><td rowspan=1 colspan=1>Chicken egg yolk</td><td rowspan=1 colspan=1>Triglycerides</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>UIBC</td><td rowspan=1 colspan=1>Endogenous and/or chemical additive</td><td rowspan=1 colspan=1>UIBC</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Urea/BUN</td><td rowspan=1 colspan=1>Endogenous and/or chemical additive</td><td rowspan=1 colspan=1>Urea</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Uric Acid</td><td rowspan=1 colspan=1>Endogenous and/or chemical additive</td><td rowspan=1 colspan=1>Uric Acid</td><td rowspan=1 colspan=1>Same</td></tr></table>

# $5 1 0 ( k )$ Summary - Calibrator for Automated Systems (C.f.a.s.) and C.f.a.s. CK-MB, Continued 5

Table 4 summarizes C.f.a.s CK-MB. It is a single analyte calibrator that contains two Creatine kinase Isoenzyme sources; CK-MB Isoenzyme is the detected analyte in the test system. For the modified C.f.a.s. CK-MB, the source material changes for one of the two CK Isoenzyme biological additives.

Constituents (continued)   
Table 4: Constituents of C.f.a.s. CK-MB   

<table><tr><td rowspan=1 colspan=2>C.f.a.s. CK-MB(Modified Device)</td><td rowspan=1 colspan=2>C.f.a.s. CK-MB K003158(Predicate Device)</td></tr><tr><td rowspan=1 colspan=1>Analyte</td><td rowspan=1 colspan=1>Source</td><td rowspan=1 colspan=1>Analyte</td><td rowspan=1 colspan=1>Source</td></tr><tr><td rowspan=1 colspan=1>CK-MBIsoenzyme</td><td rowspan=1 colspan=1>. Human recombinant CK-MBIsoenzyne. Hunan CK-MM Isoenzyme</td><td rowspan=1 colspan=1>CK-MBIsoenzyme</td><td rowspan=1 colspan=1>. Porcine brain CK-BBIsoenzyme. Human CK-MM Isoenzyme</td></tr></table>

Roche Diagnostics c/o Susan Hollandbeck Regulatory Affairs Consultant 9115 Hague Road, P.O. Box 50416 Indianapolis, IN, 46250-0416

Re: k101456 Trade Names: Calibrator for automated systems (C.f.a.s.) Calibrator for automated systems CK-MB (C.f.a.s. CK-MB) Regulation Number: 21 CFR $\ S 8 6 2 . 1 1 5 0$ EPY Regulation Name: Calibrator, Multi-Analyte Mixture and Calibrator, Secondary Regulatory Class: Class II Product Codes: JIX, JIT Dated: August 23, 2010 Received: August 24, 2010

Dear Mr. Hollandbeck:

We have reviewed your Section $5 1 0 ( \mathbf k )$ premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into class II (Special Controls), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820). This letter will alow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed

Page 2 -

predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Parts 801 and 809), please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (301) 796- 5450. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to .   
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address   
http://www.fda.gov/cdrh/industry/support/index.html.

Sincerely yours,

![](images/d7d5ea03e1221dd68df87a2b75c1df73456a49587ad115310a227078254b2cc6.jpg)

Courtney C. Harper, Ph.D.   
Director   
Division of Chemistry and Toxicology   
Office of In Vitro Diagnostic Device Evaluation and Safety Center for Devices and Radiological Health

Enclosure

# Indications for Use Form

510(k) Number(iko K 101456

Device Name:

Calibrator for automated systems (C.f.a.s.)

Indications for Use:

Calibrator for automated systems (C.f.a.s) is for use in the calibration of quantitative Roche methods on Roche clinical chemistry analyzers as specified in the value sheets.

# (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)

![](images/7a6b3bfa0744491acf0b1543d0be2b42a878a74d0590a57ab435082f3a6f6e9f.jpg)

Division Sign-Off   
Office of In Vitro Diagnostic Device   
Evaluation and Safety

510(k)K101456

# Indications for Use Form

510(k) Number (if known): K101456

Device Name:

Calibrator for automated systems (C.f.a.s.) CK-MB

Indications for Use:

C.f.a.s. (Calibrator for automated systems) CK-MB is for use in the calibration of Roche methods for the quantitative determination of CK-MB on Roche clinical chemistry analyzers as specified in the value sheets.

# (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)

![](images/1a5b4eab357d830d683dcb7bcd5c5ae512231cda108e63e98ecce371ac9de61b.jpg)

Division Sign-Off   
Office of In Vitro Diagnostic Device   
Evaluation and Safety